[Construction of recombinant adenovirus co-expressing M1 and HA genes of influenza virus type A].
Based on the human H5N1 influenza virus strain A/Anhui/1/2005, recombinant adenovirus co-expressing M1 and HA genes of H5N1 influenza virus was constructed using an internal ribosome entry site (IRES) sequence to link the two genes. The M1 and HA genes of H5N1 influenza virus were amplified by PCR and subcloned into pStar vector separately. Then the M1-IRES-HA fragment was amplified and subcloned into pShuttle-CMV vector, the shuttle plasmid was then linearized and transformed into BJ5183 bacteria which contained backbone vector pAd-Easy. The recombinant vector pAd-Easy was packaged in 293 cells to get recombinant adenovirus Ad-M1/HA. CPE was observed after 293 cells were transfected by Ad-M1/HA. The co-expression of M1 and HA genes was confirmed by Western-blot and IFA (immunofluorescence assay). The IRES containing recombinant adenovirus allowed functional co-expression of M1 and HA genes and provided the foundation for developing new influenza vaccines with adenoviral vector.
Guo
Jian-Qiang
JQ
State Key Laboratory for Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yao
Li-Hong
LH
Chen
Ai-Jun
AJ
Xu
Yi
Y
Jia
Run-Qing
RQ
Bo
Hong
H
Dong
Jie
J
Zhou
Jian-Fang
JF
Shu
Yue-Long
YL
Zhang
Zhi-Qing
ZQ
D000256:Adenoviridae / Q000235:genetics* / Q000378:metabolism; D000914:Antibodies, Viral; D015870:Gene Expression / Q000235:genetics*; D005822:Genetic Vectors / Q000494:pharmacology; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000187:drug effects*; D007252:Influenza Vaccines; D010957:Plasmids / Q000494:pharmacology*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D014765:Viral Vaccines / Q000494:pharmacology*
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D011993:Recombinant Fusion Proteins; D014765:Viral Vaccines